Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.
about
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Clinical Pharmacogenetics Impl ...... nd Oxcarbazepine: 2017 Update.
@en
Clinical Pharmacogenetics Impl ...... nd Oxcarbazepine: 2017 Update.
@nl
type
label
Clinical Pharmacogenetics Impl ...... nd Oxcarbazepine: 2017 Update.
@en
Clinical Pharmacogenetics Impl ...... nd Oxcarbazepine: 2017 Update.
@nl
prefLabel
Clinical Pharmacogenetics Impl ...... nd Oxcarbazepine: 2017 Update.
@en
Clinical Pharmacogenetics Impl ...... nd Oxcarbazepine: 2017 Update.
@nl
P2093
P2860
P50
P356
P1476
Clinical Pharmacogenetics Impl ...... and Oxcarbazepine: 2017 Update
@en
P2093
Alfred L George
Barry Goldspiel
Chonlaphat Sukasem
Daniel J Müller
Henry M Dunnenberger
Michelle Whirl-Carrillo
Roseann S Gammal
Taisei Mushiroda
Teri Klein
Wasun Chantratita
P2860
P304
P356
10.1002/CPT.1004
P407
P577
2018-02-02T00:00:00Z